Efficacy and Safety of PCSK9 Inhibitors in Hypercholesterolemia Associated With Refractory Nephrotic Syndrome

INTRODUCTION: Treatment of hypercholesterolemia in refractory nephrotic syndrome remains a therapeutic challenge. There is not enough evidence supporting the efficacy of statins, and these drugs can be associated with an increased incidence of adverse effects. Herein we summarize our clinical experi...

Full description

Saved in:
Bibliographic Details
Published in:Kidney Int Rep
Main Authors: Jatem, Elias, Lima, Joan, Montoro, Bruno, Torres-Bondia, Francisco, Segarra, Alfons
Format: Artigo
Language:Inglês
Published: Elsevier 2020
Subjects:
Clinical Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7783565/
https://ncbi.nlm.nih.gov/pubmed/33426389
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2020.09.046
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items